Widely used blood pressure medication recalled nationwide
The FDA has issued a nationwide Class II recall for 13,567 bottles of 25-milligram chlorthalidone tablets manufactured by India-based Inventia Healthcare Ltd. The recall follows the discovery that the tablets failed dissolution testing, meaning they do not dissolve properly. This marks the manufacturer's second recall of these tablets this year, bringing the total number of affected bottles to over 25,027. Patients taking the medication for blood pressure, heart failure, kidney disease, or cirrhosis are advised to check their labels, though they should not stop taking the medication without medical guidance.
Listen to Live Briefing
Real-time synthesized voice briefing ยท Live Feeds Desk
- โ Inventia Healthcare Ltd. initiated a voluntary recall of 13,567 bottles of 25-milligram chlorthalidone tablets.
- โ The tablets failed FDA dissolution testing.
- โ The FDA designated the recall as Class II.
- โ Over 25,000 bottles of the medication have been affected by recalls from this manufacturer this year.
What changed
The FDA upgraded the recall to a Class II designation and specified that 13,567 bottles of 25 mg tablets are affected in this latest action.
Live updates
-
FDA Issues Class II Recall for Inventia Healthcare Blood Pressure Medication
The FDA has issued a nationwide Class II recall for 13,567 bottles of 25-milligram chlorthalidone tablets manufactured by India-based Inventia Healthcare Ltd. The recall follows the discovery that the tablets failed dissolution testing, meaning they do not dissolve properly. This marks the manufacturer's second recall of these tablets this year, bringing the total number of affected bottles to over 25,027. Patients taking the medication for blood pressure, heart failure, kidney disease, or cirrhosis are advised to check their labels, though they should not stop taking the medication without medical guidance.
Why it matters
Chlorthalidone is a diuretic used to treat hypertension and related conditions. A Class II designation indicates a situation where use of the product may cause temporary or medically reversible adverse health consequences. The failure of dissolution specifications can impact how the drug is absorbed into the bloodstream.
What is confirmed
- Inventia Healthcare Ltd. initiated a voluntary recall of 13,567 bottles of 25-milligram chlorthalidone tablets.
- The tablets failed FDA dissolution testing.
- The FDA designated the recall as Class II.
- Over 25,000 bottles of the medication have been affected by recalls from this manufacturer this year.
- The affected medication is a diuretic used for blood pressure.
Still unconfirmed
- The recalled pills may have been prescribed to patients with heart failure, kidney disease, or cirrhosis of the liver.
- Lot RISA24002 is among the affected products.
What to watch next
- FDA announcement of any further recall classification upgrades to Class I
- Publication of a complete list of all affected lot numbers
- Reports of adverse patient reactions linked to the dissolution failure
confidence 95%Sources used for this update (23)
- www.foxbusiness.com โ Health Care
- WUSA9 โ Blood pressure medication recalled nationwide after failing FDA dissolution testing
- newsnationnow.com โ Blood pressure medication given Class II designation in recall update
- USA Today โ Blood pressure medication recalled nationwide. See affected drug
- www.usatoday.com โ Blood pressure medication recalled. See affected product
- ground.news โ Blood pressure medication recalled nationwide under FDAโs ...
- Fox Business โ Widely used blood pressure medication recalled nationwide
- NBC 5 Dallas-Fort Worth โ FDA recalls more than 13k bottles of blood pressure medication after quality issue
- flipboard.com โ FDA Updates Recalled Blood Pressure Medication to Second-Highest Level
- www.yahoo.com โ Blood pressure medication recalled nationwide. Check ... - Yahoo
- www.yahoo.com โ Widely used blood pressure medication recalled nationwide
- www.newsbreak.com โ Trump Accounts will auto-enroll children, potentially adding 60 million accounts: Treasury - NewsBreak
Community Sentiment: How do you assess this situation?
Voice your perspective ยท Real-time aggregated sentiment from the Live Feeds community